These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22577855)

  • 21. The anti-tumoral efficacy of a docetaxel-loaded liposomal drug delivery system modified with transferrin for ovarian cancer.
    Yuan MQ; Zhu F; Lou JY; Yuan WM; Fu L; Liu S; Zhang ZZ; Liu CY; He Q
    Drug Res (Stuttg); 2014 Apr; 64(4):195-202. PubMed ID: 24154938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokinetics.
    Qu G; Wu X; Yin L; Zhang C
    Biomed Pharmacother; 2012 Feb; 66(1):46-51. PubMed ID: 22264883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
    Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
    Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction.
    Guo BH; Cheng Y; Lin LP; Lin DH; Wu W
    J Liposome Res; 2011 Sep; 21(3):255-60. PubMed ID: 21545336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Salvianolic acid B-Tanshinone II A-Glycyrrhetinic acid compound liposomes: formulation optimization and its effects on proliferation of hepatic stellate cells.
    Lin J; Wang X; Wu Q; Dai J; Guan H; Cao W; He L; Wang Y
    Int J Pharm; 2014 Feb; 462(1-2):11-8. PubMed ID: 24374609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, characterization and pharmacokinetics of N-palmitoyl chitosan anchored docetaxel liposomes.
    Liang G; Jia-Bi Z; Fei X; Bin N
    J Pharm Pharmacol; 2007 May; 59(5):661-7. PubMed ID: 17524231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycyrrhetinic Acid Liposomes Containing Mannose-Diester Lauric Diacid-Cholesterol Conjugate Synthesized by Lipase-Catalytic Acylation for Liver-Specific Delivery.
    Chen J; Chen Y; Cheng Y; Gao Y
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28946644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin.
    Wei M; Xu Y; Zou Q; Tu L; Tang C; Xu T; Deng L; Wu C
    Eur J Pharm Sci; 2012 Jun; 46(3):131-41. PubMed ID: 22369856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation of liposomes surface-modified with glycyrrhetinic acid targeting to hepatocytes].
    Mao SJ; Hou SX; Jin H; Zhang LK; Jiang-Bin
    Zhongguo Zhong Yao Za Zhi; 2003 Apr; 28(4):328-31. PubMed ID: 15139140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
    Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
    Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects.
    Jiang H; Li ZP; Tian GX; Pan RY; Xu CM; Zhang B; Wu JL
    Int J Nanomedicine; 2019; 14():1789-1804. PubMed ID: 30880980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced distribution and extended elimination of glycyrrhetinic acid in mice liver by mPEG-PLA modified (mPEGylated) liposome.
    Li J; Yu H; Li S; Wang GJ
    J Pharm Biomed Anal; 2010 Apr; 51(5):1147-53. PubMed ID: 20005656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced targeted delivery of adenine to hepatocellular carcinoma using glycyrrhetinic acid-functionalized nanoparticles in vivo and in vitro.
    Wu F; Xue H; Li X; Diao W; Jiang B; Wang W; Yu W; Bai J; Wang Y; Lian B; Feng W; Sun T; Qu M; Zhao C; Wang Y; Wu J; Gao Z
    Biomed Pharmacother; 2020 Nov; 131():110682. PubMed ID: 32947204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus.
    Zhang Q; Zhang X; Chen T; Wang X; Fu Y; Jin Y; Sun X; Gong T; Zhang Z
    Nanoscale; 2015; 7(20):9298-310. PubMed ID: 25945919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
    Wang X; Gu X; Wang H; Yang J; Mao S
    Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
    Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
    Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
    Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
    Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier.
    Lv Y; Li J; Chen H; Bai Y; Zhang L
    Int J Nanomedicine; 2017; 12():4361-4370. PubMed ID: 28652738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation.
    Tian JL; Ke X; Chen Z; Wang CJ; Zhang Y; Zhong TC
    Pharmazie; 2011 May; 66(5):362-7. PubMed ID: 21699070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.